VANGUARD GROUP INC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 84 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 2.41 and the average weighting 0.7%.

Quarter-by-quarter ownership
VANGUARD GROUP INC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$259,026,930
-22.4%
8,191,870
+0.1%
0.01%
-25.0%
Q2 2023$333,790,457
+10.1%
8,185,151
+0.6%
0.01%0.0%
Q1 2023$303,108,637
+11.2%
8,132,778
+4.1%
0.01%
+14.3%
Q4 2022$272,498,785
-26.4%
7,810,226
+18.0%
0.01%
-36.4%
Q3 2022$370,305,000
+9.9%
6,617,323
+1.7%
0.01%
+22.2%
Q2 2022$336,920,000
-27.5%
6,509,282
+1.8%
0.01%
-18.2%
Q1 2022$464,502,000
-39.0%
6,391,940
-0.8%
0.01%
-35.3%
Q4 2021$761,744,000
-10.6%
6,442,355
+1.4%
0.02%
-19.0%
Q3 2021$852,299,000
-12.6%
6,353,334
+5.4%
0.02%
-12.5%
Q2 2021$975,698,000
+117.9%
6,026,177
+8.0%
0.02%
+100.0%
Q1 2021$447,722,000
+60.4%
5,578,744
+8.7%
0.01%
+50.0%
Q4 2020$279,137,000
+220.8%
5,131,197
+17.2%
0.01%
+166.7%
Q3 2020$87,010,000
-2.8%
4,376,799
+2.8%
0.00%0.0%
Q2 2020$89,486,000
+109.8%
4,257,196
+22.0%
0.00%
+50.0%
Q1 2020$42,661,000
-17.5%
3,488,249
-1.0%
0.00%0.0%
Q4 2019$51,701,000
+12.2%
3,524,199
+2.1%
0.00%0.0%
Q3 2019$46,092,000
-11.6%
3,452,461
+8.4%
0.00%0.0%
Q2 2019$52,124,000
+8.5%
3,184,116
+13.2%
0.00%0.0%
Q1 2019$48,035,000
+28.1%
2,812,392
+2.4%
0.00%0.0%
Q4 2018$37,485,000
-50.6%
2,746,126
+3.5%
0.00%
-33.3%
Q3 2018$75,934,000
+17.3%
2,653,165
+12.2%
0.00%0.0%
Q2 2018$64,720,000
+52.7%
2,365,483
+17.7%
0.00%
+50.0%
Q1 2018$42,381,000
+20.1%
2,009,513
+9.4%
0.00%0.0%
Q4 2017$35,297,000
+35.9%
1,836,481
+75.7%
0.00%
+100.0%
Q3 2017$25,976,000
+62.8%
1,045,293
+4.8%
0.00%0.0%
Q2 2017$15,957,000
+25.2%
997,288
+10.2%
0.00%0.0%
Q1 2017$12,747,000
+11.7%
904,708
+3.9%
0.00%0.0%
Q4 2016$11,416,000
+52.6%
870,783
+98.1%
0.00%
Q3 2016$7,483,000
-15.9%
439,630
+5.5%
0.00%
-100.0%
Q2 2016$8,894,000416,5640.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2017
NameSharesValueWeighting ↓
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 1,216,340$62,958,0007.04%
Discovery Value Fund 584,483$30,253,0006.33%
MPM BioImpact LLC 299,409$15,497,0004.30%
ARK Investment Management 9,514,580$439,003,0002.60%
Elmwood Wealth Management, Inc. 67,899$3,514,0002.00%
Nikko Asset Management Americas, Inc. 2,781,136$141,143,0001.74%
Avidity Partners Management LP 1,125,194$58,240,0001.34%
Merlin Capital, Inc 12,174$630,0001.26%
Atlas Venture Associates IX, LLC 10,000$518,0001.18%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$5,768,0001.16%
View complete list of INTELLIA THERAPEUTICS INC shareholders